ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Suppression of T Cell Proliferation by Activated Nonhuman Primate B Cells

K. Lee, K. Deng, G. Huai, F. Qiang, C. Rickert, J. Lei, C. Leguern, J. Markmann

Massachusetts General Hospital, Boston, MA

Meeting: 2021 American Transplant Congress

Abstract number: 521

Keywords: B cells, Immunosuppression, T cell reactivity, T cells

Topic: Basic Science » B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: We previously generated Toll-like receptor (TLR)-activated B cells in rodent settings. These B cells can suppress T cell proliferation via in vitro mixed lymphocytes reaction and promote allograft tolerance as Regulatory B cells (Bregs). A continuous effort toward Bregs drove us to generate TLR-activated B cells in Nonhuman primates using the same protocol in the murine model. In this study, we evaluated the efficacy of their phenotype, function, and mechanism to suppress T cell responses.

*Methods: Purified splenic NHP B cells were activated with CpG ODN 2006-5G for 3 days with the addition of LPS, PMA, and ionomycin for the last 5 hours. They were then harvested and co-cultured with CFSE-labeled autologous T cells stimulated with polyclonal CD3/CD28 beads or PHA. On day 4, proliferation was measured by flow cytometry. In some cultures, anti-PD1, or anti-GzmB was added to evaluate their role in suppressing T cell proliferation.

*Results: The majority of CpG/LPI-NHP B cells had immature phenotypes, CD20+CD21+CD27-IgM+ on surface. In in vitro experiment, they effectively suppressed CD4+ and CD8+ T cell proliferation and reduced their viability upon stimulation, while B cells with only CpG activation did not. The CpG/LPI-NHP B cells expressed higher levels of LAP, a surrogate marker for TGF-β, and programmed death (PD1), but not expressed a higher level of IL-10 compared to naïve NHP B cells. Instead, it seemed that Granzyme B (GzmB) was instrumental to the suppressive effect because the blockade of GzmB increased the proliferation in the coculture.

*Conclusions: We have successfully generated NHP Bregs with in vitro suppressive capacity toward T cell responses. Here we show for the first time that CpG-activated NHP B cells exert regulatory function. Our studies suggest that Bregs may provide a great option for regulatory cell-based therapy. We are pursuing the translational potential of Bregs in a large animal model by evaluating their regulatory function in vivo.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee K, Deng K, Huai G, Qiang F, Rickert C, Lei J, Leguern C, Markmann J. Suppression of T Cell Proliferation by Activated Nonhuman Primate B Cells [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/suppression-of-t-cell-proliferation-by-activated-nonhuman-primate-b-cells/. Accessed May 10, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences